Barinthus Biotherapeutics plc (NASDAQ: BRNS)1y Target Est 4.50
Index - P/E - EPS (ttm) -1.49 Insider Own 9.11% Shs Outstand 39.54M Perf Week 5.14%
Market Cap 40.33M Forward P/E - EPS next Y -1.44 Insider Trans 0.00% Shs Float 35.94M Perf Month 3.34%
Income -58.07M PEG - EPS next Q -0.37 Inst Own 15.59% Short Float 0.04% Perf Quarter 3.81%
Sa
